PhenoPath's Acquisition

PhenoPath was acquired by Quest Diagnostics on September 27, 2018.

PhenoPath provides AP, molecular oncology and other services including genetic sequencing and genomic tumor analysis.…

Articles about PhenoPath's Acquisition: